GlassScriptPhysician profile
Anna Caitlin Paylor
NPI 1134654056
$10,941.81
in general payments reported to CMS, 2019-2025
43 companies · $3,693 in 2025
The $3,693 reported for 2025 was more than what 98% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,723 · 2022: $1,526 · 2023: $1,463 · 2024: $2,535 · 2025: $3,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,248 · Consulting Fee: $350 · Education: $93.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,248.10 |
| Consulting Fee | $350.00 |
| Education | $93.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,871.02 | 2021-2025 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $1,262.01 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,226.76 | 2021-2025 | Ofev, Jascayd, Stiolto Respimat |
| Takeda Pharmaceuticals U.S.A., INC. | $585.38 | 2021-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $526.34 | 2023-2025 | Dupixent |
| Genzyme Corporation | $499.76 | 2021-2025 | |
| Philips North America LLC | $473.78 | 2021-2024 | (Ak6) Vest Therapy |
| Jazz Pharmaceuticals INC. | $471.79 | 2021-2025 | |
| United Therapeutics Corporation | $390.25 | 2021-2025 | Tyvaso, Tyvaso |
| Axsome Therapeutics, INC. | $385.63 | 2023-2025 | Sunosi |
| Insmed, INC. | $369.03 | 2021-2025 | Arikayce |
| Merck Sharp & Dohme LLC | $333.74 | 2024-2025 | Zerbaxa, Recarbrio, Keytruda |
| Avadel Cns Pharmaceuticals, LLC | $308.96 | 2024-2025 | Lumryz |
| Mylan Specialty L.P. | $238.20 | 2021-2024 | Yupelri |
| Grifols USA, LLC | $221.47 | 2021-2025 | Prolastin-C Liquid, Xembify |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $211.49 | 2023-2025 | Tezspire |
| Teva Pharmaceuticals USA, INC. | $163.47 | 2021-2023 | Airduo Digihaler |
| Electromed, INC. | $151.28 | 2021-2025 | Smartvest |
| Verona Pharma, INC. | $146.92 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $127.28 | 2023-2025 | Opsumit, Uptravi |
| Harmony Biosciences LLC | $113.27 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $104.54 | 2021-2024 | Acthar |
| Genentech USA, INC. | $95.30 | 2022-2025 | Xolair |
| Sanofi-Aventis U.S. LLC | $81.93 | 2021-2025 | |
| Ani Pharmaceuticals, INC. | $73.39 | 2024-2025 | Purified Cortrophin Gel |
| Viatris Specialty LLC | $68.51 | 2025 | Yupelri |
| Baxter Healthcare | $59.29 | 2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Volara System |
| Lilly USA, LLC | $34.96 | 2025 | Zepbound |
| Vifor Pharma, INC. | $34.58 | 2024 | Zemaira |
| Inogen, INC. | $33.44 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $32.73 | 2025 | |
| Resmed Corp | $30.75 | 2025 | |
| Inari Medical, INC. | $26.26 | 2022 | |
| Stryker Corporation | $24.92 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Inspire Medical Systems, INC. | $24.31 | 2025 | Inspire |
| Advanced Respiratory, INC | $24.29 | 2021 | |
| Tactile Systems Technology INC | $23.88 | 2025 | Nimbl, Flexitouch Plus |
| Pfizer INC. | $21.01 | 2024 | |
| Almatica Pharma LLC | $15.82 | 2023 | Loreev Xr |
| Idorsia Pharmaceuticals US INC | $15.18 | 2023 | Quviviq |
| Paratek Pharmaceuticals, INC. | $13.98 | 2025 | Nuzyra |
| Phadia US INC. | $12.80 | 2021 | |
| Ethicon INC. | $12.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Paylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.